Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.
about
Expression and significance of GRHL2 in esophageal cancer.Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathwayLymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View.Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.Effect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells.Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinomaTumor lymphangiogenesis as a potential therapeutic target.Clinical implications of PTEN and VEGF expression status, as well as microvessel density in esophageal squamous cell carcinomaPrognostic value of vascular endothelial growth factor-C and podoplanin mRNA expression in esophageal cancer.Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancerVascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgeryThe role of the VEGF-C/VEGFRs axis in tumor progression and therapy.The non-canonical role of vascular endothelial growth factor-C axis in cancer progressionAngiogenesis-related molecular targets in esophageal cancer.Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.Overexpression of VEGF-C correlates with a poor prognosis in esophageal cancer patients.Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF-C in Human Colon Cancer.Relationship between expression and prognostic ability of PTEN, STAT3 and VEGF-C in colorectal cancer.APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model.Correlation of CD146 expression and clinicopathological characteristics in esophageal squamous cell carcinoma.FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma.microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma.High levels of circulating CD34+/VEGFR3+ lymphatic/vascular endothelial progenitor cells is correlated with lymph node metastasis in patients with epithelial ovarian cancer.Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma.Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets.siRNA blocking the RAS signalling pathway and inhibits the growth of oesophageal squamous cell carcinoma in nude mice.Serum vascular endothelial growth factor-C levels predict lymph node metastasis and prognosis of patients with gallbladder cancerClinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma
P2860
Q33563241-BFF8A66B-687A-4CAA-9226-40F616435FD3Q34003819-E99832E5-53B9-4440-ACC1-ADE7C033A29DQ34658684-1DC7F970-9222-4FC5-B5B9-995E8A9E5C71Q35037270-85A10DB9-8A8A-47B3-B490-91B6F219CC0CQ35307690-C6C2EC18-83B1-4C90-8CFC-0CA3749BBC06Q35549652-C536E4C0-9CA0-433F-8FC8-974E8320CEEAQ35838122-CC6626EE-E288-47E6-AE7C-F756C93A6C3FQ35943250-61F64015-8D48-4707-B0AB-01EFA4FCA2A2Q36336498-E6B1FBB0-9C6F-4AB2-A9EA-F69E17762887Q36367559-A3146851-6750-4B65-A683-7C1981EAAC4EQ36439514-ECEF0248-303A-4B53-A98F-0C51BFE3109AQ36589860-9FAFB872-ECF7-4BE2-82C7-ADC5BD6C5EFCQ37071029-0D5DCD4F-2C17-45F3-A7B4-E961D15912D9Q37858534-FE31B2ED-62DC-4AD0-9972-6CBB22C8241BQ38957389-96325DB4-1D93-49C4-86AF-259261AF4287Q40615441-9F22CB08-2D5C-460D-8A37-6C18FEF66724Q40886377-B594C874-9BFA-4C20-85CD-054326947C7BQ41492330-8CF741B3-B670-4D7D-B303-60DA85FC168EQ41593187-D02E4CB7-0E22-4668-8444-FF2A19F557E6Q42006550-BE4FAB16-5133-4E04-B719-07A7CBFD406EQ42371598-386111F6-473A-4625-B0C2-BB33E62D26B9Q44056340-0E282CF8-3ABA-421C-9B9B-3AFF352A15D5Q46231311-69B4D84C-D483-473B-B463-FF771746789FQ48206628-7249FD25-07CC-4F68-9DD3-2B68417BA6C7Q54280680-E8F564E1-9E57-40DF-8C0B-BC3F9D563F83Q54296511-F3B3419E-578E-4533-8387-7F7671720913Q55025461-F3E63A40-6A5E-46F3-B3AF-32C39FAFA1CFQ55069973-78F05118-5725-46C2-BE94-1AB7BF542A80Q57788704-4E091C6E-FFDB-4613-A624-4F5FBB5D0E95Q58787284-86AC2DA4-E7DC-4132-A650-36650316F2E1
P2860
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vascular endothelial growth fa ...... is and poor patient prognosis.
@ast
Vascular endothelial growth fa ...... is and poor patient prognosis.
@en
type
label
Vascular endothelial growth fa ...... is and poor patient prognosis.
@ast
Vascular endothelial growth fa ...... is and poor patient prognosis.
@en
prefLabel
Vascular endothelial growth fa ...... is and poor patient prognosis.
@ast
Vascular endothelial growth fa ...... is and poor patient prognosis.
@en
P2093
P2860
P356
P1476
Vascular endothelial growth fa ...... is and poor patient prognosis.
@en
P2093
Akira Mitsui
Hideyuki Ishiguro
Hiromitsu Takeyama
Masahiro Kimura
Midori Shiozaki
Takeyasu Katada
Tatsuya Tanaka
Yasuhiro Naganawa
Yoshitaka Fujii
Yoshiyuki Kuwabara
P2860
P2888
P356
10.1186/1756-9966-29-83
P577
2010-06-28T00:00:00Z
P5875
P6179
1040821285